Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.
Thomas J Oxley,J Mocco,Shahram Majidi,Christopher P. Kellner,Hazem Shoirah,I. Paul Singh,Reade De Leacy,Tomoyoshi Shigematsu,Travis R. Ladner,Kurt A. Yaeger,Maryna Skliut,Jesse Weinberger,Neha S. Dangayach,Joshua B. Bederson,Stanley Tuhrim,Johanna T Fifi +15 more
Reads0
Chats0
TLDR
Five patients younger than 50 years of age with large-vessel stroke and Covid-19 infection presented to a health system in New York City over a 2-week period with signs of stroke and infection.Abstract:
Stroke in Young Patients with Covid-19 Five patients younger than 50 years of age with large-vessel stroke and Covid-19 infection presented to a health system in New York City over a 2-week period....read more
Citations
More filters
Journal ArticleDOI
Spectrum of neuropsychiatric manifestations in COVID-19.
Krishna Nalleballe,Sanjeeva Onteddu,Rohan Sharma,Vasuki Dandu,Aliza T. Brown,Madhu Jasti,Sisira Yadala,Karthika Veerapaneni,Suman Siddamreddy,Akshay Avula,Nidhi Kapoor,Kamran Mudassar,Sukanthi Kovvuru +12 more
TL;DR: Early recognition and prompt management of neuropsychiatric manifestations in patients diagnosed with COVID-19 have a potential to decrease overall morbidity and mortality.
Journal ArticleDOI
COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
James B. Caress,Ryan Castoro,Zachary Simmons,Stephen N. Scelsa,Richard A. Lewis,Aditi Ahlawat,Pushpa Narayanaswami +6 more
TL;DR: GBS‐associated COVID‐19 appears to be an uncommon condition with similar clinical and EDx patterns to GBS before the pandemic, and future studies should compare patients with COvid‐19–associated GBS to those with contemporaneous non–COVID‐ 19 GBS and determine whether the incidence of GBS is elevated in those with CO VID‐19.
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.
Adnan I Qureshi,William I. Baskett,Wei Huang,Daniel Shyu,Danny Myers,Murugesan Raju,Iryna Lobanova,M. Fareed K. Suri,S. Hasan Naqvi,Brandi R French,Farhan Siddiq,Camilo R Gomez,Chi-Ren Shyu +12 more
TL;DR: In this article, the authors studied the risk factors, in-hospital events, and outcomes of acute ischemic stroke in patients with coronavirus disease 2019 (COVID-19).
Journal ArticleDOI
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry.
George Ntaios,Patrik Michel,Georgios Georgiopoulos,Yutao Guo,Wencheng Li,Jing Xiong,Patricia Calleja,Fernando Ostos,Guillermo González-Ortega,Blanca Fuentes,María Alonso de Leciñana,Exuperio Díez-Tejedor,Sebastián García-Madrona,Jaime Masjuan,Alicia DeFelipe,Guillaume Turc,Bruno Gonçalves,Bruno Gonçalves,Valerie Domigo,Gheorghe Andrei Dan,Roxana Vezeteu,Hanne Christensen,Louisa M. Christensen,Per Meden,Lejla Hajdarevic,Ángela Rodríguez-López,Fernando Díaz-Otero,Andrés García-Pastor,Antonio Gil-Núñez,Errikos Maslias,Davide Strambo,David J. Werring,Arvind Chandratheva,Laura A Benjamin,Robert Simister,Richard J. Perry,Rahma Beyrouti,Pascal Jabbour,Ahmad Sweid,Stavropoula Tjoumakaris,Elisa Cuadrado-Godia,Ana Rodríguez Campello,Jaume Roquer,Tiago Moreira,Michael V. Mazya,Fabio Bandini,Karl Matz,Helle K. Iversen,Alejandra González-Duarte,Cristina Tiu,Julia Ferrari,Milan R. Vosko,Helmut J. F. Salzer,Bernd Lamprecht,Martin W. Dünser,Carlo W. Cereda,Ángel Basilio Corredor Quintero,Eleni Korompoki,Eduardo Soriano-Navarro,Luis Enrique Soto-Ramírez,Paulo F. Castañeda-Méndez,Daniela Bay-Sansores,Antonio Arauz,Vanessa Cano-Nigenda,Espen Saxhaug Kristoffersen,Espen Saxhaug Kristoffersen,Marjaana Tiainen,Daniel Strbian,Jukka Putaala,Gregory Y.H. Lip,Gregory Y.H. Lip +70 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus as a source of infection for other animals.
References
More filters
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).
T. Umapathi,Ai Ching Kor,Narayanaswamy Venketasubramanian,C. C. Tchoyoson Lim,Boon Chuan Pang,Tseng Tsai Yeo,Cheng Chuan Lee,Poh Lian Lim,Poh Lian Lim,Kuperan Ponnudurai,Khoon Leong Chuah,Puay Hoon Tan,Dessmon Y.H. Tai,Sze Peng Brenda Ang +13 more
TL;DR: It is believed that increased vigilance against stroke and other thrombotic complications among critically-ill SARS patients in future outbreaks is needed, especially if treatment such as intravenous immunoglobulin, that increases pro-thrombosis tendency, is contemplated.
Journal ArticleDOI
Erythropoietin as candidate for supportive treatment of severe COVID-19.
Hannelore Ehrenreich,Karin Weissenborn,Martin Begemann,Martin Begemann,Markus Busch,Eduard Vieta,Kamilla W. Miskowiak +6 more
TL;DR: Evidence that supports the use of human recombinant erythropoietin (EPO) for ameliorating course and outcome of seriously ill COVID-19 patients is recap here and the research design for a double-blind placebo-controlled randomized clinical trial including severely affected patients is planned to start shortly.
Journal ArticleDOI
Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
TL;DR: The objective of this study was to establish a baseline for the evaluation of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.
Journal ArticleDOI
COVID-19-associated pulmonary and cerebral thromboembolic disease
TL;DR: A case of a 79-year-old woman that presented with stroke and was found to have COVID-19 pneumonia and concomitant large burden pulmonary arterial clot is reported.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more